Today: 5 July 2026
authID (AUID) stock price dips in premarket after a 72% surge on ServiceNow integration news
16 January 2026
1 min read

authID (AUID) stock price dips in premarket after a 72% surge on ServiceNow integration news

New York, January 16, 2026, 08:46 EST — Premarket update.

  • authID shares slipped roughly 11% in premarket trading to $1.52, following a 72% jump on Thursday’s close.
  • The company announced it developed a ServiceNow integration to handle biometric identity checks within contact centers.
  • With U.S. markets closed Monday for Martin Luther King Jr. Day, traders are focused on whether the open will extend recent momentum.

Shares of authID Inc slipped 11% to around $1.52 in premarket action on Friday, pulling back from Thursday’s surge. The Nasdaq-listed stock had soared 72.3% to close at $1.71 the previous day, on volume nearing 295 million shares. Its market capitalization stands near $26 million.

authID unveiled an integration with ServiceNow that lets contact-center agents authenticate callers through biometrics—like face scans—before approving account changes or risky transactions. The company says this rollout targets over 8,400 ServiceNow-powered contact centers worldwide, including clients representing 85% of the Fortune 500. It’s now available on the ServiceNow Store. “Our integration with ServiceNow empowers its global customer base to protect user accounts while improving the user experience,” CEO Rhon Daguro said. GlobeNewswire

The reason this matters now is clear: call centers have turned into a soft target for “account takeover” scams, where fraudsters manipulate agents into resetting passwords, altering access, or moving money. Solutions that integrate easily with existing software agents use quickly grab interest—especially among smaller players.

ServiceNow stands as a major player in workflow software for large enterprises. Should the integration catch on, authID could reach security teams and operations managers quickly—no lengthy deployment required.

Friday’s premarket drop highlighted a key trait of micro-cap tech stocks: they often move sharply when momentum traders jump in, then flip direction just as fast. Despite the early slide, the stock remains well above Wednesday’s close.

Biometrics can replace traditional “knowledge-based” checks—security questions and personal details that are often guessed or purchased—but the method faces ongoing scrutiny. Privacy regulations, obtaining customer consent, and the possibility of false matches remain persistent challenges for the industry.

Execution risk remains a concern. Just because an app is listed or integrated doesn’t guarantee paid rollouts. Bigger players in identity and cybersecurity are already vying for those budgets.

Traders will be watching to see if Thursday’s rally sticks when regular trading kicks off at 9:30 a.m. EST. Attention also turns to authID—will it deliver customer wins or reveal more on how the integration is rolling out?

U.S. markets will be shut Monday, January 19, in observance of Martin Luther King Jr. Day and resume trading Tuesday, January 20. This holiday shortens the week, potentially squeezing liquidity and concentrating catalyst-driven moves into a handful of sessions.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • PepsiCo (PEP) Rebounds Off Lows, Up 2% Before Q2 Numbers
    July 5, 2026, 9:39 AM EDT. PepsiCo (NASDAQ: PEP) rose 2% to $143, coming off its 52-week low of $132.96. Shares remain 11% below the year high of $159. First-quarter 2026 revenue was up 8.5% to $19.44 billion, and core EPS came in at $1.61, both above expectations. North American food sales volumes grew 2% as demand for smaller packages picked up. PepsiCo lifted its annual dividend 4%, now yielding about 4.19%, marking the 53rd straight increase. UBS lowered its target to $172 but kept a Buy, pointing to a good outlook despite softness in the stock. Barclays and other analysts have become more careful on the name.
Eli Lilly stock slides premarket after FDA sets April 10 target for weight-loss pill decision, GLP-1 lawsuit filed
Previous Story

Eli Lilly stock slides premarket after FDA sets April 10 target for weight-loss pill decision, GLP-1 lawsuit filed

Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings
Next Story

Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings

Go toTop